Xinglu Zhou

1.2k total citations
60 papers, 904 citations indexed

About

Xinglu Zhou is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Xinglu Zhou has authored 60 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Plant Science. Recurrent topics in Xinglu Zhou's work include Genetic Mapping and Diversity in Plants and Animals (7 papers), Acute Myeloid Leukemia Research (6 papers) and Synthesis and biological activity (5 papers). Xinglu Zhou is often cited by papers focused on Genetic Mapping and Diversity in Plants and Animals (7 papers), Acute Myeloid Leukemia Research (6 papers) and Synthesis and biological activity (5 papers). Xinglu Zhou collaborates with scholars based in China, Czechia and United States. Xinglu Zhou's co-authors include Qiaojun He, Bo Yang, Hui Jing, Lei Zhong, Yongzhou Hu, Zhiyuan Xu, Jie Qin, Peihua Luo, Yujie Shi and Xiaowu Dong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Xinglu Zhou

56 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinglu Zhou China 18 410 177 142 105 77 60 904
Navneet Dogra United States 14 375 0.9× 138 0.8× 193 1.4× 56 0.5× 33 0.4× 28 716
Zhigang Sui China 18 809 2.0× 245 1.4× 222 1.6× 116 1.1× 78 1.0× 57 1.2k
Yunus Akkoç Türkiye 16 603 1.5× 110 0.6× 296 2.1× 84 0.8× 54 0.7× 28 1.1k
Yongtao Li China 23 583 1.4× 79 0.4× 135 1.0× 175 1.7× 42 0.5× 98 1.3k
Yao Peng China 22 466 1.1× 188 1.1× 129 0.9× 114 1.1× 182 2.4× 74 1.1k
Xiaobo Sheng China 13 359 0.9× 114 0.6× 71 0.5× 203 1.9× 127 1.6× 26 836
Bohan Ma China 18 537 1.3× 233 1.3× 55 0.4× 190 1.8× 107 1.4× 44 919
Hyungu Kang South Korea 18 616 1.5× 236 1.3× 52 0.4× 45 0.4× 109 1.4× 34 1.0k
Risako Onodera Japan 20 450 1.1× 126 0.7× 52 0.4× 51 0.5× 54 0.7× 64 1.0k

Countries citing papers authored by Xinglu Zhou

Since Specialization
Citations

This map shows the geographic impact of Xinglu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinglu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinglu Zhou more than expected).

Fields of papers citing papers by Xinglu Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinglu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinglu Zhou. The network helps show where Xinglu Zhou may publish in the future.

Co-authorship network of co-authors of Xinglu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xinglu Zhou. A scholar is included among the top collaborators of Xinglu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinglu Zhou. Xinglu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jia, Fan, Da‐Yong Hou, Han Zhang, et al.. (2025). Synthesis, preclinical evaluation and clinical application of a novel heterodimeric tracer 68Ga-pentixafor-c(RGDfK) for PET-CT imaging. European Journal of Nuclear Medicine and Molecular Imaging. 53(3). 1593–1607.
2.
Zhou, Xinglu, et al.. (2025). The predictive function of miR-122-5p and its action mechanism by regulating PKM2 in metabolic syndrome. BMC Endocrine Disorders. 25(1). 54–54.
4.
Dong, Xiaowu, Yu Guo, Jingyu Zhang, et al.. (2024). Potent in Vitro and In Vivo Efficacy of Hdz-C123A, a GSPT1 Degrader-Antibody Conjugate Targeting CD123 in Acute Myeloid Leukemia. Blood. 144(Supplement 1). 156–156. 2 indexed citations
5.
Song, Yuqin, Ningjing Lin, Xingguo Liu, et al.. (2024). Preclinical and First-in-Human Phase I Study of Bruton Tyrosine Kinase Degrader HZ-Q1070 in Patients with Recurrent or Refractory B-Cell Malignancies. Blood. 144(Supplement 1). 6286–6286. 2 indexed citations
6.
Li, Xia, et al.. (2024). Melatonin improves cadmium tolerance in Salix viminalis by enhancing amino acid and saccharide metabolism, and increasing polyphenols. Ecotoxicology and Environmental Safety. 288. 117393–117393. 5 indexed citations
7.
8.
Du, Changjian, Min Zhang, Xinglu Zhou, et al.. (2023). Revealing the relationship between nitrogen use efficiency‐related QTLs and carbon and nitrogen metabolism regulation in poplar. GCB Bioenergy. 15(5). 575–592. 6 indexed citations
9.
Zhang, Lei, et al.. (2023). Insight into growth and wood properties based on QTL and eQTL mapping in Populus deltoides ‘Danhong’ × Populus simonii ‘Tongliao1’. Industrial Crops and Products. 199. 116731–116731. 4 indexed citations
10.
Xu, Wei, Bin Lin, Conghua Ji, et al.. (2023). HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells. Frontiers in Pharmacology. 14. 1142127–1142127. 2 indexed citations
11.
Zhou, Xinglu, et al.. (2023). Populus cathayana genome and population resequencing provide insights into its evolution and adaptation. Horticulture Research. 11(1). uhad255–uhad255. 5 indexed citations
12.
Zhou, Xinglu, et al.. (2022). Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma. SHILAP Revista de lepidopterología. 5 indexed citations
13.
Liu, Lianyong, Xinglu Zhou, Juan Chen, & Xiangqi Li. (2022). Potential of ATP5MG to Treat Metabolic Syndrome-Associated Cardiovascular Diseases. Frontiers in Cardiovascular Medicine. 9. 921778–921778. 2 indexed citations
14.
Zhang, Yu, et al.. (2020). LncRNA MAGI2-AS3 Affects Cell Invasion and Migration of Cervical Squamous Cell Carcinoma (CSCC) via Sponging miRNA-233/EPB41L3 Axis. SHILAP Revista de lepidopterología.
15.
Zhong, Lei, Xinglu Zhou, Juan Li, et al.. (2015). The T-SPOT.TB Test for Diagnosis of Breast Tuberculosis. Laboratory Medicine. 46(1). 14–19. 6 indexed citations
16.
Ying, Meidan, Xinglu Zhou, Like Zhong, et al.. (2012). Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All- Trans -Retinoic Acid–Induced Differentiation by Modifying the RARα/STAT1 Axis. Molecular Cancer Therapeutics. 12(2). 195–206. 36 indexed citations
17.
Fang, Yanfen, Xinglu Zhou, Meihua Lin, et al.. (2010). Inhibition of all‐Trans‐retinoic acid‐induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells. Molecular Carcinogenesis. 50(1). 24–35. 20 indexed citations
18.
Ye, Qing, Ji Cao, Xinglu Zhou, et al.. (2009). Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors. Bioorganic & Medicinal Chemistry. 17(13). 4763–4772. 25 indexed citations
19.
Cao, Ji, Lei Zhang, Qing Ye, et al.. (2009). YQ36: A Novel Bisindolylmaleimide Analogue Induces KB/VCR Cell Death. BioMed Research International. 2009(1). 535072–535072. 1 indexed citations
20.
Xu, Guiqing, Chong Zhang, Lei Zhang, et al.. (2008). Synthesis, Cytotoxicity and Protein Kinase C Inhibition of Arylpyrrolylmaleimides. Archiv der Pharmazie. 341(5). 273–280. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026